Doxorubicin-induced DNA damage was significantly increased in lymphoma cell lines exposed to a Pim kinase inhibitor, in association with significant downregulation of the DNA DSB response proteins H2AX, ATM and Chk2 [57]. The gene discussed is CHEK2; the disease is lymphoma.